Adverse reactions to medications are common and may have a variety of clinical
presentations in the oral cavity. Targeted therapies and the new biologic agents have …

For decades, it has been known that patients with certain autoimmune and inflammatory
disorders, such as rheumatoid arthritis (RA) and primary Sjögren's syndrome (pSS), have an …

Other iatrogenic immunodeficiency-associated lymphoproliferative disorders (OIIA-LPD), a
category of immunodeficiencyassociated LPD according to the World Health Organization …

Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, affecting up to 90% of the population.
EBV was first identified as an oncogenic virus in a Burkitt lymphoma cell line, though …

Methotrexate (MTX) carries a risk of lymphoproliferative disorders (LPDs), but MTX-
associated LPDs (MTX-LPDs) can resolve spontaneously after MTX withdrawal. However …

Rheumatoid arthritis (RA) is one of the most common autoimmune diseases, with a 0.5%
worldwide prevalence. The cause of RA remains unknown, however both genetic and …

In this review, we focus on B-cell lymphoproliferative disorders (LPDs) and lymphomas
associated with Epstein–Barr virus (EBV). In some of these diseases—such as EBV-positive …

Patients with rheumatoid arthritis (RA) have a greater risk of developing both Hodgkin
lymphoma (HL) and non‐HL than the general population. Non‐Hodgkin lymphoma is more …

Objectives: The 2015 Workshop of the Society for Hematopathology/European Association
for Haematopathology aimed to review B-cell proliferations of varied malignant potential …

Objective To compare the efficacy and safety between tocilizumab added to methotrexate
and tocilizumab switched from methotrexate in patients with active rheumatoid arthritis (RA) …